Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1009-2023Class II

Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which...

Abbott Molecular, Inc. / initiated 2022-12-09 / Open, Classified / root cause: manufacturing process

Abbott Molecular, Inc. began a recall of Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplification, detection... on . FDA classified it as Class II and gives the reason as "The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board value (calibration...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1009-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Abbott Molecular, Inc.
Product
Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplification, detection, and data reduction.
Product code
OOI Real Time Nucleic Acid Amplification System
Reason for recall
The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board value (calibration data file) referenced causing a misconfiguration of the calibration. 2. Inability of Maintenance and Diagnostics 2300 (Amp Detect Optical Calibrations) to recognize error handling and thermal hold errors during the calibration process, potentially leading to a misconfiguration of the calibration. 3. Under specific conditions during the ADU manufacturing process, an incorrect calibration may potentially have been configured.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
On December 09, 2022, Abbott Molecular issued a Field Correction Recall/Urgent Field Safety Notice to all customers who have the Alinity m System by FedEx priority overnight express. The letter explained the problems and provided the following information: "An assessment of your Alinity m System associated with the above listed potential issues will be completed remotely if your system is currently connected to AbbottLink or alternatively via onsite inspection by an Abbott representative. If necessary, an Abbott representative will schedule time to corrected the affected ADU9s) on your Alinity m System(s). In the interim, please continue to follow your laboratory protocols for any suspected incorrect results. Following the assessment and any necessary service, an additional communication will follow. If it is determined that your instrument was impacted, please assess the impact to your laboratory in reviewing previously generated test results. This recall is to be carried out at the user/customer level. If this product has been further distributed by your facility, please notify any additional impacted customers. Please review this information with laboratory personnel and retain this communication for future reference. If you have any questions regarding the communication, please contact your local Abbott representative, or call Abbott Technical Support at 1-800-553-7042 Option 2."
Quantity in commerce
918 units
Distribution
x
Product codes and lots
Model Number: 08N53-002

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1009-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1009-2023Class IIOngoingVoluntary: Firm initiated